Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
"Cardinal Infrastructure Group" Full Year 2025 Earnings Call - Record $682M Backlog and M&A plus vertical integration power a 2026 guide above 20% adjusted EBITDA
Cardinal closed 2025 with a strong growth burst, a December IPO, and a company-record $682 million backlog, then quickly bolted on a large Georgia acquisition to push 2026 guidance toward $665 million...
- Revenue grew 45% in 2025 to $456 million, with approximately 33% organic growth year-over-year.
- Company completed its IPO in December 2025, and raised nearly $140 million through financing activities during the year.
- Year-end backlog hit a company record $682 million, roughly 1.5x 2025 revenue, providing strong coverage for 2026 guidance.
- +14 more takeaways
Lifezone Metals 2025 Full Year Earnings Call - Kabanga on the cusp of FID as strategic funding and project finance paths converge
Lifezone presented a tightly scripted march toward a final investment decision for the Kabanga Nickel Project. The company published a bankable feasibility study in July 2025 showing a $1.58 billion a...
- Feasibility study published July 2025 yields after-tax NPV of $1.58 billion and a 23.3% IRR, placing Kabanga in the lower quartile cost curve versus peers.
- Lifezone has completed resettlement actions and S-K 1300 initial assessment, advancing development readiness and social license in Tanzania.
- A $60 million senior secured bridge facility from Taurus Mining Finance is ring-fenced for Kabanga; $20 million drawn in 2025 and a further $5 million drawn as a subsequent event.
- +12 more takeaways
Darden Restaurants Fiscal 2026 Q3 Earnings Call - Same-Restaurant Sales Outperformance Widens, Guidance Raised
Darden reported a strong Fiscal 2026 third quarter, with total sales of $3.3 billion (up 5.9%) and same-restaurant sales up 4.2%, widening its outperformance versus the casual dining benchmark. Manage...
- Q3 results: Total sales $3.3 billion, up 5.9% year-over-year; same-restaurant sales +4.2% and outperformed the Black Box Intelligence casual dining benchmark by ~540 basis points.
- Company raised full-year cadence: now expects FY26 total sales growth of ~9.5%, same-restaurant sales ~4.5%, about 70 new restaurant openings, commodities inflation ~4%, and adjusted diluted EPS $10.57-$10.67 (includes ~ $0.25 from a 53rd week).
- Q4 implied guide: total sales growth 13.0%-14.5% (includes extra week), same-restaurant sales 3.5%-5.0%, and adjusted diluted EPS $3.59-$3.69.
- +14 more takeaways
Destination XL Group Q4 2025 Earnings Call - FiTMAP rollout and FullBeauty merger provide strategic runway as comps lag
Destination XL closed FY25 with comps that kept the chain in retreat, reporting Q4 comparable sales down 7.3% and full-year comps down 8.4%, hit hardest by a January Arctic storm that knocked a third ...
- Comparable sales declined 7.3% in Q4 2025, with stores down 8.6% and direct down 4.3%; full-year comparable sales fell 8.4%.
- January was heavily impacted by severe Arctic weather, pushing January comps to minus 12.9%; management reports a rebound with February at minus 1.3% and March following a similar trend.
- Management expects comps to improve through H1 2026, target break even before summer, and turn positive later in the year; no formal fiscal 2026 guidance will be issued until after the FullBeauty merger closes.
- +12 more takeaways
ACCESS Newswire Q4 2025 Earnings Call - Subscription Pivot and Product-Led ARR Lift
ACCESS Newswire closed 2025 as a leaner, subscription-first company, delivering flat top-line but clear product momentum. Q4 revenue was $5.8 million, gross margin held at 77%, adjusted EBITDA remaine...
- Q4 revenue was $5.8 million, essentially flat sequentially and roughly flat year-over-year; full year 2025 revenue was $22.6 million, down about 2% from 2024.
- Gross margin improved to 77% in Q4 and for the full year, up from 75%/76% in the comparable 2024 periods, attributed to headcount efficiencies and fixed-cost leverage, partially offset by higher distribution spend.
- Adjusted EBITDA for Q4 was $881,000 (15% of revenue), roughly flat year-over-year; full-year adjusted EBITDA rose to $3.2 million or 14% of revenue, showing margin progress despite flat revenue.
- +12 more takeaways
NeurAxis Q4 2025 Earnings Call - CPT Code Flip, Payer Coverage Remains the Gatekeeper for IB-Stim Growth
NeurAxis framed Q4 and early 2026 as the moment the IB-Stim commercialization story moves from access creation to execution. A Category I CPT code effective January 1, 2026, plus new payer wins and a ...
- Category I CPT code for IB-Stim became effective January 1, 2026, shifting the company from access creation to commercial execution.
- NeurAxis added roughly 45 million covered lives via a major national insurer policy in December 2025, bringing total covered lives above 100 million for PENFS/IB-Stim.
- Payers do not provide coverage based solely on the CPT code, written medical policy coverage remains essential to reimbursement and volume.
- +16 more takeaways
Taysha Gene Therapies Full Year 2025 Earnings Call - FDA alignment and REVEAL pivotal launch set a possible 6-month pathway to BLA
Taysha presented a tightly choreographed advance toward registration for TSHA-102, anchored by FDA written alignment on trial design, CMC comparability, and a 6-month interim analysis for the REVEAL p...
- Taysha initiated the REVEAL pivotal trial in Q4 2025 and has dosed multiple patients, with company guidance to complete pivotal and ASPIRE dosing in Q2 2026.
- FDA provided written alignment on the REVEAL pivotal and ASPIRE trial designs, including acceptance of a 6-month interim analysis for the REVEAL pivotal trial.
- TSHA-102 has Breakthrough Therapy designation from the FDA, granted in September 2025.
- +12 more takeaways
Chicago Atlantic BDC, Inc. Q4 2025 Earnings Call - High-yield, low-leverage cannabis-focused BDC signals readiness while markets fret about private credit
Chicago Atlantic reported Q4 2025 NII of $0.36 per share and $1.45 for the year, underscoring a high-yield, low-leverage strategy centered on senior secured debt to largely cannabis and lower middle m...
- Q4 2025 net investment income was $0.36 per share, and $1.45 for the full year.
- Management cites a yield to book value of 2.7% for Q4 and 11% for the full year as evidence of the business model.
- Gross weighted average yield on debt investments was 15.8%, versus the average public BDC yield of 10.8% cited by management.
- +15 more takeaways
Datavault AI Q4 2025 Earnings Call - Reiterates $200M 2026 Revenue Target as NYIAX, IBM and Fiserv Fuel Tokenization Push
Datavault AI closed 2025 claiming a turning point. Management reported the company’s first GAAP profitable quarter with adjusted EBITDA north of $8 million, pared down debt and more than $115 million ...
- Company reported its first ever profitable GAAP quarter in Q4 2025, with adjusted EBITDA exceeding $8 million.
- Management said it substantially eliminated debt and finished the year with over $115 million in working capital.
- Datavault reiterated full-year 2026 revenue guidance of $200 million, expecting sequential growth each quarter and a majority of revenue weighted to H2 2026.
- +14 more takeaways
Movado Group, Inc. Fourth Quarter 2026 Earnings Call - Returned to growth, but tariffs shave roughly 150 basis points from margins
Movado closed fiscal 2026 by returning to growth after a tough prior year, with revenue up 2.7% to $671.3 million and adjusted operating income rising 28.7% to $34.8 million. Momentum accelerated into...
- Revenue returned to growth in fiscal 2026, up 2.7% year over year to $671.3 million; Q4 sales rose 5.6% to $191.6 million.
- Adjusted operating income jumped 28.7% for the year to $34.8 million, and Q4 adjusted operating income grew 6.2% to $14.4 million.
- Gross margin held nearly flat at about 54.1% to 54.2% despite external pressures, helped by favorable channel and product mix and operating leverage.
- +12 more takeaways